A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients

ConditionBruxism
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-25
SponsorBeni-Suef University

About this trial

This study examines the effect of electromyography biofeedback on masticatory muscles hyperactivity on patients with bruxism.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Twenty adult subjects with definite mild to moderate bruxism examined by a dentist prior to the study.

Tenderness of masticatory muscles on palpation grade one and two according to the digital palpating scale

Mild to moderate myofascial pain around the temporomandibular joint causing discomfort in the morning.

Disqualifiers

Took any Botox or PRP injection treatment for this condition for the last six months

Had any advanced periodontal disease.

Any intraoral fixed splints.

Pregnancy.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Electromyography biofeedback

    Other intervention

    Participants in the experimental group will receive surface electromyography (SEMG) feedback training, targeting the Masseter muscle, for 40 minutes per session according to the Evidence-Based practice since longer practice may become counterproductive due to fatigue and loss of focus. The frequency of the sessions will be 3 sessions/week for 4 weeks.

  • Pharmacotherapy

    Drug

    Pharmacotherapy will be received by all participants in the two groups in the form of multi relaxant (cyclobenzaprine) 10 MG twice daily for 4 weeks \& anti inflammatory (non steroidal anti-inflammatory drugs).

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Electromyography biofeedback + PharmacotherapyExperimental treatment 2 interventions
Group B: PharmacotherapyOther 1 intervention

Trial outcomes

Primary outcomes

1

Assessment of Masseter Hyperactivity

The assessment of Masseter muscle hyperactivity will be carried out by the digital palpating scale according to the following criteria: Grade Zero (0): when the muscle palpated and there is no pain or tenderness reported by the patient. Grade (1): Recorded if the patient response the palpation is uncomfortable (tenderness or soreness). Grade (2): is recorded if the patient experiences definite discomfort or pain. Grade (3): is recorded if the patient shows evasive action or eye tearing or verbalizes a desire not to have the area palpated again.

Time frame
4 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: